An Efficient Synthesis of Amides and Esters via Triacyloxyboranes

Zhongping Huang; John E. Reilly; Ronald N. Buckle

doi:10.1055/s-2007-973890

LETTER

An Efficient Synthesis of Amides and Esters via Triacyloxyboranes

Zhongping Huang*, John E. Reilly, Ronald N. Buckle
Department of Medicinal Chemistry, Albany Molecular Research Inc., Albany, NY 12212, USA
Fax: +1(518)4640289; e-Mail: zhongping.huang@albmolecular.com ;

Abstract

Alle Artikel dieser Rubrik

Abstract

Borane-tetrahydrofuran complex or borane-methyl sulfide complex is used to activate carboxylic acids to generate triacyloxyboranes. The triacyloxyboranes can be effectively reacted with various nucleophiles including alkylamines, arylamines, hydrazides, alcohols and phenols at reflux in toluene to provide the corresponding amides and esters in excellent yield. Aliphatic carboxylic acids are selectively esterified in the presence of aromatic carboxylic acids under the borane conditions.

Key words

triacyloxyboranes - amides - esters - borane-tetrahydrofuran complex - borane-methyl sulfide complex - selectivity

Volltext

Referenzen

References and Notes

1a Smith MB. March J. March’s Advanced Organic Chemistry 5th ed.: John Wiley and Sons, Inc.; New York, NY: 2001. Chap. 10. p.512

1b Druzian J. Zucco C. Rezende MC. Nome F. J. Org. Chem. 1989, 54: 4767

1c Deshpande MS. Tetrahedron Lett. 1994, 35: 5613

2a Pelter A. Levitt TE. Nelson P. Tetrahedron 1970, 26: 1539

2b Pelter A. Levitt TE. Nelson P. Tetrahedron 1970, 26: 1545

3 Collum DB. Chen S. Ganem B. J. Org. Chem. 1978, 43: 4393

4a Ishihara K. Ohara S. Yamamoto H. J. Org. Chem. 1996, 61: 4196

4b Maki T. Ishihara K. Yamamoto H. Synlett 2004, 1355

4c Maki T. Ishihara K. Yamamoto H. Org. Lett. 2005, 7: 5043

4d Maki T. Ishihara K. Yamamoto H. Org. Lett. 2005, 7: 5047

4e Maki T. Ishihara K. Yamamoto H. Org. Lett. 2006, 8: 1431

5 Houston TA. Wilkinson BL. Blanchfield JT. Org. Lett. 2004, 6: 679

6 Brown HC. Stocky TP. J. Am. Chem. Soc. 1977, 99: 8218

7

General Procedure for Formation of Amides and Esters: To a carboxylic acid (1-2 mmol) in toluene (10 mL) was added a solution of borane-THF (1 M) in THF in an ice bath. The mixture was warmed to r.t. for 1 h. An amine or an alcohol was added and the mixture was heated at reflux for 12 h or 24 h. The resulting mixture was cooled to r.t. and treated with HCl (1 M), and then diluted with EtOAc (20 mL). The organic phase was washed with H₂O and concentrated under reduced pressure and purified by flash chromatography. The physical data of compounds are provided below.
N -Butylhexanamide (Table 3, Entry 1): ¹H NMR (500 MHz, CDCl₃): δ = 5.37 (br s, 1 H), 3.25 (t, J = 7.0 Hz, 2 H), 2.14 (t, J = 8.0 Hz, 2 H), 1.64-1.60 (m, 2 H), 1.47-1.46 (m, 2 H), 1.36-1.30 (m, 6 H), 0.94-0.88 (m, 6 H). ¹³C NMR (125 MHz, CDCl₃): δ = 170.6, 36.8, 34.5, 29.4, 29.1, 23.1, 20.0, 17.7, 11.5, 11.4. APCI-MS: m/z = 172 [M⁺].
1-Morpholinononan-1-one (Table 3, Entry 2): ¹H NMR (500 MHz, CDCl₃): δ = 3.68-3.61 (m, 6 H), 3.48-3.44 (m, 2 H), 2.33-2.28 (m, 2 H), 1.62-1.55 (m, 2 H), 1.30-1.27 (m, 10 H), 0.90-0.85 (m, 3 H). ¹³C NMR (125 MHz, CDCl₃): δ = 171.9, 66.9, 66.7, 46.0, 41.8, 33.1, 31.8, 29.4, 29.3, 29.1, 25.2, 22.6, 14.0. APCI-MS: m/z 228 [M⁺].
N -Benzylcyclohexanecarboxamide (Table 3, Entry 3): ¹H NMR (500 MHz, CDCl₃): δ = 7.34-7.26 (m, 5 H), 5.70 (br s, 1 H), 4.44 (d, J = 5.6 Hz, 2 H), 2.16-2.05 (m, 1 H), 1.90-1.87 (m, 2 H), 1.80-1.78 (m, 2 H), 1.60-1.59 (m, 1 H), 1.47-1.45 (m, 2 H), 1.28-1.22 (m, 3 H). ¹³C NMR (75 MHz, CDCl₃): δ = 175.8, 138.5, 128.7, 127.7, 127.4, 45.6, 43.4, 29.7, 25.7. APCI-MS: m/z 218 [M⁺].
N -Benzyl-4-methylbenzamide (Table 3, Entry 4):² ¹H NMR (500 MHz, CDCl₃): δ = 7.69 (d, J = 8.1 Hz, 2 H), 7.36 (d, J = 4.3 Hz, 4 H), 7.31-7.33 (m, 1 H), 7.23-7.22 (m, 2 H), 6.32 (br s, 1 H), 4.65 (d, J = 5.6 Hz, 2 H), 2.39 (s, 3 H). ¹³C NMR (125 MHz, CDCl₃): δ = 167.2, 141.9, 138.3, 131.5, 129.2, 128.7, 127.9, 127.6, 126.9, 44.1, 21.4. APCI-MS: m/z = 226 [M⁺].
N -Benzyl-2-methylbenzamide (Table 3, Entry 5): ¹H NMR (500 MHz, CDCl₃) δ = 7.38-7.35 (m, 5 H), 7.32-7.28 (m, 2 H), 7.22-7.18 (m, 2 H), 6.10 (br s, 1 H), 4.64 (d, J = 5.7 Hz, 2 H), 2.47 (s, 3 H). ¹³C NMR (75 MHz, CDCl₃): δ = 169.8, 138.1, 136.2, 136.2, 131.0, 129.9, 128.8, 127.8, 127.6, 126.6, 125.7, 43.9, 19.8. APCI-MS: m/z = 226 [M⁺].
N -Benzyl-3-cyanobenzamide (Table 3, Entry 6): ¹H NMR (300 MHz, CDCl₃): δ = 8.08 (s, 1 H), 8.07 (d, J = 8.1 Hz, 2 H), 8.03 (d, J = 7.9 Hz, 1 H), 7.79 (t, J = 7.5 Hz, 1 H), 7.37-7.33 (m, 5 H), 6.47 (br s, 1 H), 4.65 (d, J = 5.6 Hz, 2 H). ¹³C NMR (125 MHz, CDCl₃): δ = 165.1, 137.5, 135.6, 134.7, 131.2, 130.7, 129.6, 128.9, 128.0, 127.9, 117.9, 113.0, 44.4. APCI-MS: m/z = 237 [M⁺].
N , N -Diphenylacetamide (Table 3, Entry 7): ¹H NMR (300 MHz, CDCl₃): δ = 7.36-7.28 (m, 10 H), 2.05 (s, 3 H). ¹³C NMR (125 MHz, CDCl₃): δ = 170.4, 129.6, 128.9, 126.4, 23.8. APCI-MS: m/z = 212 [M⁺].
N ′-(Cyclohexanecarbonyl)-4-methylbenzenesulfono-hydrazide (Table 3, Entry 8): ¹H NMR (500 MHz, CDCl₃): δ = 7.78 (d, J = 8.2 Hz, 2 H), 7.52 (d, J = 6.0 Hz, 1 H), 7.30 (d, J = 8.0 Hz, 2 H), 7.23 (d, J = 6.2 Hz, 1 H), 2.42 (s, 3 H), 1.99-1.97 (m, 1 H), 1.70-1.68 (m, 2 H), 1.63-1.60 (m, 3 H), 1.21-1.13 (m, 5 H). ¹³C NMR (75 MHz, CDCl₃): δ = 174.0, 144.8, 133.0, 129.4, 128.7, 43.0, 28.9, 25.3, 25.2, 21.7. APCI-MS: m/z = 297 [M⁺].

8

Methyl 2-Hydroxy-2-phenylacetate (Table 4, Entry 1): ¹H NMR (300 MHz, CDCl₃): δ = 7.41-7.34 (m, 5 H), 5.19 (d, J = 5.6 Hz, 1 H), 3.76 (s, 3 H), 3.44 (d, J = 5.6 Hz, 1 H). ¹³C NMR (125 MHz, CDCl₃): δ = 174.1, 138.2, 128.6, 126.6, 120.0, 72.9, 53.0.
Butyl Hexanoate (Table 4, Entry 2): ¹H NMR (300 MHz, CDCl₃): δ = 4.09 (t, J = 6.6 Hz, 2 H), 2.31 (t, J = 7.4 Hz, 2 H), 1.63-1.60 (m, 4 H), 1.36-1.30 (m, 6 H), 0.95-0.87 (m, 6 H). ¹³C NMR (125 MHz, CDCl₃): δ = 174.0, 64.1, 34.3, 31.3, 30.7, 24.7, 22.3, 19.1, 13.9, 13.7.
4-Bromophenyl Acetate (Table 4, Entry 3): ¹H NMR (500 MHz, CDCl₃): δ = 7.50 (d, J = 6.7 Hz, 2 H), 7.00 (d, J = 6.7 Hz, 2 H), 2.29 (s, 3 H). ¹³C NMR (125 MHz, CDCl₃): δ = 169.1, 149.6, 132.4, 123.3, 118.9, 21.0.
4-Methoxyphenyl Acetate (Table 4, Entry 4): ¹H NMR (300 MHz, CDCl₃): δ = 7.01 (d, J = 6.7 Hz, 2 H), 6.90 (d, J = 6.7 Hz, 2 H), 3.79 (s, 3 H), 2.28 (s, 3 H). ¹³C NMR (125 MHz, CDCl₃): δ = 169.1, 157.2, 144.2, 122.3, 114.4, 55.5, 21.0.
4-Cyanophenyl Acetate (Table 4, Entry 5): ¹H NMR (300 MHz, CDCl₃): δ = 7.71 (d, J = 8.8 Hz, 2 H), 7.26 (d, J = 8.8 Hz, 2 H), 2.33 (s, 3 H). ¹³C NMR (125 MHz, CDCl₃): δ = 168.4, 153.9, 133.6, 122.7, 118.2, 109.7, 21.1.
4-Bromophenyl Cyclohexanecarboxylate (Table 4, Entry 6): ¹H NMR (300 MHz, CDCl₃): δ = 7.48 (d, J = 6.7 Hz, 2 H), 6.96 (d, J = 6.7 Hz, 2 H), 2.58-2.51 (m, 1 H), 2.08-2.00 (m, 2 H), 1.88-1.80 (m, 2 H), 1.74-1.50 (m, 3 H), 1.47-1.37 (m, 3 H). ¹³C NMR (125 MHz, CDCl₃): δ = 174.2, 149.9, 132.3, 123.3, 118.6, 43.1, 28.9, 25.6, 25.3.
2-{[(Benzyloxy)carbonyl]methyl}benzoic Acid (Table 4, Entry 7): ¹H NMR (300 MHz, CDCl₃): δ = 8.15 (d, J = 7.7 Hz, 1 H), 7.55 (t, J = 6.1 Hz, 1 H), 7.44 (t, J = 8.5 Hz, 1 H), 7.34-7.28 (m, 6 H), 5.15 (s, 2 H), 4.11 (s, 2 H). ¹³C NMR (125 MHz, CDCl₃): δ = 171.3, 136.7, 135.9, 133.3, 132.4, 131.9, 128.5, 128.2, 128.1, 127.6, 66.6, 40.7. APCI-MS: m/z = 269 [M^-].